AstraZeneca Continues Early-Stage Deal-Making Spree with Alchemia Deal
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 5 (Table of Contents)
Published: 2 May-2013
DOI: 10.3833/pdr.v2013.i5.1929 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AstraZeneca has partnered with Australian biotech Alchemia to discover and develop novel small molecule drug candidates against multiple AstraZeneca targets utilising Alchemia’s VAST™ (Versatile Assembly on Stable Templates) chemistry platform...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS